ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,018.39
-0.34%
Dow Jones
37,903.29
0.23%
US Dollar vs MXN
16.9453
0.01%
Brent Oil
83.895
0.42%
Bitcoin
57,321.01
-1.57%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Tempest Therpeutics Inc (TPST)

  7. Tempest Therpeutics Inc (TPST) Noticias

TPST Tempest Therpeutics Inc

3.70
0.23 (6.63%)
01 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Tempest Therpeutics Inc TPST NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.23 6.63% 3.70 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
3.47 3.4201 3.67 3.62 3.47
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
26/4/202415:05GLOBETempest Reports Inducement Grant Under Nasdaq Listing Rule..
09/4/202407:00GLOBETempest Reports New Preclinical Data for TPST-1120 in RCC at..
04/4/202407:00GLOBETempest Announces Publication of Positive Data from Phase 1..
19/3/202415:25GLOBETempest Reports Year End 2023 Financial Results and Provides..
12/3/202407:00GLOBETempest Presents New Data at the SITC 2024 Spring Scientific..
05/3/202415:30GLOBETempest Announces Upcoming Presentation of Preclinical Data..
26/2/202407:00GLOBETempest to Present at the 44th Annual TD Cowen Healthcare..
14/2/202417:49EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202413:12EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/2/202416:41EDGAR2Form SC 13D/A - General statement of acquisition of..
02/2/202415:30GLOBETempest Reports Inducement Grant Under Nasdaq Listing Rule..
05/1/202415:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202415:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202415:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202415:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202415:05GLOBETempest Reports Inducement Grant Under Nasdaq Listing Rule..
01/12/202315:15GLOBETempest Reports Inducement Grant Under Nasdaq Listing Rule..
20/11/202307:00GLOBETempest to Present at the 35th Annual Piper Sandler..
17/11/202315:46EDGAR2Form S-8 POS - Securities to be offered to employees in..
17/11/202315:45EDGAR2Form S-8 POS - Securities to be offered to employees in..
17/11/202315:44EDGAR2Form S-8 POS - Securities to be offered to employees in..
17/11/202315:44EDGAR2Form S-8 POS - Securities to be offered to employees in..
17/11/202315:43EDGAR2Form S-8 POS - Securities to be offered to employees in..
17/11/202315:39EDGAR2Form S-8 - Securities to be offered to employees in employee..
09/11/202316:28EDGAR2Form SC 13D/A - General statement of acquisition of..
08/11/202316:25EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/11/202316:18EDGAR2Form 8-K - Current report
08/11/202316:17GLOBETempest Reports Third Quarter 2023 Financial Results and..
02/11/202315:16EDGAR2Form 144 - Report of proposed sale of securities
30/10/202305:06EDGAR2Form 8-K - Current report
13/10/202315:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/10/202315:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/10/202315:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/10/202315:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/10/202305:06EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
11/10/202307:29EDGAR2Form 8-A12B - Registration of securities [Section 12(b)]
11/10/202307:13EDGAR2Form 8-K - Current report
11/10/202307:01GLOBETempest Adopts Limited Duration Stockholder Rights Plan
11/10/202307:00GLOBETempest Releases New Data Demonstrating Superiority of..
10/10/202315:05GLOBETempest to Report New and Updated Data from Global..
19/9/202307:00GLOBETempest Announces Expanded Role for Sam Whiting, M.D.,..
08/9/202315:16EDGAR2Form 8-K - Current report
07/9/202315:19EDGAR2Form 8-K - Current report
05/9/202307:00GLOBETempest to Present at the H.C. Wainwright 25th Annual Global..
10/8/202315:39EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202315:27EDGAR2Form 8-K - Current report
10/8/202315:13GLOBETempest Reports Second Quarter 2023 Financial Results and..
19/7/202307:00GLOBETempest Announces Publication in Cancer Research..
31/5/202315:05GLOBETempest to Present at the Jefferies Global Healthcare..
25/5/202316:00GLOBETempest to Present Phase 1 Monotherapy and Combination Data..

Su Consulta Reciente

NASDAQ
TPST
Tempest Therpeutics
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados